Form 4: Clover Health Director Boosts Stake with $1M Share Purchase

Clover Health Investments Director and 10% owner Vivek Garipalli acquired 446,980 shares of Class A Common Stock for approximately $1 million.

Summary

• Vivek Garipalli, a Director and 10% owner of Clover Health Investments, Corp. (CLOV), purchased additional shares of the company's Class A Common Stock.
• On August 7, 2025, Mr. Garipalli acquired 415,000 shares at a weighted average price of $2.24 per share, totaling approximately $929,600. The transaction prices ranged from $2.16 to $2.32.
• On August 8, 2025, an additional 31,980 shares were purchased at a weighted average price of $2.17 per share, totaling approximately $69,416.60. The transaction prices ranged from $2.15 to $2.21.
• Following these transactions, Mr. Garipalli directly owns 1,856,247 shares of Class A Common Stock.
• Mr. Garipalli also directly holds 6,904,343 shares of Class B Common Stock, which are convertible into Class A Common Stock on a one-to-one basis.
• Indirectly, Mr. Garipalli beneficially owns 11,500,000 shares of Class B Common Stock through Ceasar Clover, LLC and 72,084,543 shares of Class B Common Stock through NJ Healthcare Investments, LLC, where he serves as the sole manager of both entities.
• The total beneficial ownership, including convertible Class B shares, amounts to 92,345,133 shares.

Sentiment

Score: 8

Explanation: The significant insider buying by a director and 10% owner, Vivek Garipalli, indicates strong confidence in the company's future prospects and current valuation, which is a highly positive signal for investors.

Positives

• Significant insider buying by a Director and 10% owner, Vivek Garipalli, signals strong confidence in the company's future prospects and current valuation.
• The substantial investment of approximately $1 million by a key insider suggests a belief that the stock is undervalued or poised for growth.

Future Outlook

This filing, a Form 4, reports insider transactions and does not provide forward-looking statements or guidance on the company's future outlook.

Industry Context

This insider buying activity by a key executive and significant shareholder in Clover Health, a healthcare technology company, could be interpreted by the market as a positive signal amidst the evolving landscape of digital health and managed care, where investor confidence in long-term growth strategies is crucial.

Stakeholder Impact

• Shareholders may view this significant insider purchase as a strong vote of confidence from a key executive and major owner, potentially leading to increased investor interest and positive sentiment.
• Employees might perceive this as a sign of stability and belief in the company's long-term vision from its leadership.

Key Dates

Recommendation

The substantial share purchases by a key insider, who is both a director and a 10% owner, signals strong conviction in Clover Health's valuation and future performance. This action suggests management believes the stock is undervalued or poised for growth, making it an attractive entry point for investors.

Keywords

Clover Health, CLOV, Insider Buying, Stock Purchase, Vivek Garipalli, Form 4, Director Purchase, 10% Owner, Healthcare Investments